African Pharmaceutical Regulatory Intelligence
ESOMEPRAZOLE
283 registrations across 15 African markets— 189 active
Markets with ESOMEPRAZOLE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Esofag- 40 Tablet | 🇰🇪Kenya | Micro Labs Limited | active | May 2031 |
| CP-ESOMEPRAZOLE POWDER/INJECTABLE; INJECTION | 🇿🇼Zimbabwe | COSPHARM INVESTMENTS PVT LTD | active | Mar 2031 |
| Esomeprazole 20mg GR Capsules (Each hard gelatin capsules contains Esomeprazole USP 20mg) | 🇬🇭Ghana | — | active | Dec 2030 |
| Esomeprazole 20mg GR Capsules (Each hard gelatin capsules contains Esomeprazole USP 20mg) | 🇬🇭Ghana | — | active | Dec 2030 |
| ESGEAR 20 TABLET; ORAL | 🇿🇼Zimbabwe | PHARMAQON, | active | Nov 2030 |
| ESGEAR 40 TABLET; ORAL | 🇿🇼Zimbabwe | PHARMAQON, | active | Nov 2030 |
| ZERCYM Lyophilized injection white powder or cake | 🇷🇼Rwanda | EVEREST ORGANICS LIMITED | active | Oct 2030 |
| Esaktive 40 tablets Tablet Uncoated | 🇿🇲Zambia | Sava Healthcare Limited | active | Jul 2030 |
| TRUSFLUKS 20 | 🇿🇦South Africa | Innovata Pharmaceuticals | active | Oct 2029 |
| TRUSFLUKS 40 | 🇿🇦South Africa | Innovata Pharmaceuticals | active | Oct 2029 |
| Es-Omecos Tablets | 🇷🇼Rwanda | COSMOS LIMITED | active | Aug 2029 |
| ZOEGAS-40 Capsules | 🇷🇼Rwanda | LABORATOIRES COOPER PHARMA | active | Aug 2029 |
| ZOEGAS-20 Capsules | 🇷🇼Rwanda | LABORATOIRES COOPER PHARMA | active | Aug 2029 |
| MAGPRAZ 40 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | MYLAN LABORATORIES LIMITED [OTL] | active | Dec 2028 |
| MAGPRAZ 20 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | MYLAN LABORATORIES LIMITED [OTL] | active | Dec 2028 |
| REVOLE 40mg CAPSULES (Each delayed release capsule contains Esomeprazole 40mg) | 🇬🇭Ghana | — | active | Nov 2028 |
| REVOLE 40mg CAPSULES (Each delayed release capsule contains Esomeprazole 40mg) | 🇬🇭Ghana | — | active | Nov 2028 |
| Esoquin 20mg Capsule Capsule | 🇰🇪Kenya | ALFAJIRI PHARMACEUTICALS LTD | active | Aug 2028 |
| ESOFAST BQT-L KIT Tablet | 🇰🇪Kenya | Innocia Lifesciences Pvt. Ltd | active | Sept 2027 |
| Tamesyere | 🇬🇭Ghana | — | active | Sept 2027 |
| Tamesyere | 🇬🇭Ghana | — | active | Sept 2027 |
| Es-Loprot I.V Injection 40mg Injection | 🇰🇪Kenya | Nabiqasim Industries (Pvt) Ltd | active | Jul 2027 |
| Ezium Capsules 40mg Capsule, Hard | 🇰🇪Kenya | THE SEARLE COMPANY LIMITED | active | Apr 2027 |
| Eso-Q 40mg Tablet Tablet | 🇰🇪Kenya | Q PHARMA DMCC | active | Jan 2027 |
| Eso-Q 20mg Tablet Tablet | 🇰🇪Kenya | Q PHARMA DMCC | active | Jan 2027 |
| Ezium Capsules 20mg Capsule, Hard | 🇰🇪Kenya | THE SEARLE COMPANY LIMITED | active | Sept 2026 |
| ESONEA INJECTION Injection | 🇰🇪Kenya | NESHER PHARMA LD | active | Aug 2026 |
| NESOPRAM 40 | 🇿🇦South Africa | Ranbaxy (SA) (Pty) Ltd | suspended | Sept 2025 |
| ESORAN 40 | 🇿🇦South Africa | Ranbaxy (SA) (Pty) Ltd | suspended | Sept 2025 |
| NESOPRAM 20 | 🇿🇦South Africa | Ranbaxy (SA) (Pty) Ltd | suspended | Sept 2025 |
| ESOZ 20MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2025 |
| MAGPRAZ_20 20MG GASTR RESISTANT TABLET GASTR RESISTANT TABLET | 🇲🇼Malawi | — | expired | Mar 2025 |
| MAGPRAZ_40 40MG GASTRO RESISTANT TABLET GASTRO RESISTANT TABLET | 🇲🇼Malawi | — | expired | Mar 2025 |
| ESOFAG_40 40MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2025 |
| ESOZ 40MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2025 |
| ESOMEPRAZ OLE CAPSULES CAPSULES X 2 X 7 | 🇳🇬Nigeria | ECOMED PHARMA. LTD. PLOT 32 | expired | Jun 2023 |
| ESOMEPRAZ OLE CAPSULE CAPSULE | 🇳🇬Nigeria | ECOMED PHARM LTD PLOT 32 LYNSON CHEMICAL AVENUE | expired | Aug 2022 |
| NEXIUM 40 Comprimé gastro-résistant / 40 mg | 🇹🇳Tunisia | ASTRA ZENECA UK LIMITED | expired | Jan 2022 |
| ESOREST-20 TABLETS TABLET | 🇳🇬Nigeria | NEMEL PHARMACEUTI CAL NIGERIA LIMITED PLOT 35 | expired | Nov 2021 |
| NEXIUM 20 MG Comprimé gastro-résistant / 20 mg | 🇹🇳Tunisia | ASTRA ZENECA UK LIMITED | expired | Oct 2021 |
| NEXIUM 20 TABLET TABLET/2X7 | 🇳🇬Nigeria | ASTRAZENECA NIG. LTD. 18A | expired | Oct 2021 |
| RGEO Gélule gastrorésistante / 40 mg | 🇹🇳Tunisia | SAIPH | expired | Aug 2021 |
| RGEO Gélule gastrorésistante / 40 mg | 🇹🇳Tunisia | SAIPH | expired | Aug 2021 |
| ENOMERAL 20 Gélule gastrorésistante / 20 mg | 🇹🇳Tunisia | TAHA PHARMA | expired | Jun 2021 |
| ENOMERAL 20 Gélule gastrorésistante / 20 mg | 🇹🇳Tunisia | TAHA PHARMA | expired | Jun 2021 |
| ENOMERAL 20 Gélule gastrorésistante / 20 mg | 🇹🇳Tunisia | TAHA PHARMA | expired | Jun 2021 |
| ENOMERAL 40 Gélule gastrorésistante / 40 mg | 🇹🇳Tunisia | TAHA PHARMA | expired | Jun 2021 |
| ENOMERAL 40 Gélule gastrorésistante / 40 mg | 🇹🇳Tunisia | TAHA PHARMA | expired | Jun 2021 |
| ENOMERAL 40 Gélule gastrorésistante / 40 mg | 🇹🇳Tunisia | TAHA PHARMA | expired | Jun 2021 |
| ESOMAX Gélule gastrorésistante / 40 mg | 🇹🇳Tunisia | DAR-ESSAYDALI. | expired | Apr 2021 |
Showing 50 of 283 registrations. Sign up free to search and export all.
ESOMEPRAZOLE in Africa — Regulatory Overview
ESOMEPRAZOLE is registered across 15 African markets with 283 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Senegal, South Africa, Madagascar and 11 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 283 registrations, 189 (67%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.